Inventor

Brent R. Stockwell

Inventor
New York, NY, US

Overview

22→
Patents
2002–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds26%
A61KPreparations for medical, dental or toiletry purposes21%
G01NInvestigating or analysing materials by determining their chemical or physical properties16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C07CAcyclic or carbocyclic compounds12%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry4%
C40BCombinatorial chemistry4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
PatentTitleYear
10,947,188Small molecule ferroptosis inducers202110,597,381Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders202010,259,775Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders201910,233,171Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders20199,938,245Carbonyl erastin analogs and their use20189,926,293'Multivalent RAS binding compounds'20189,695,133'Quinazolinone-based oncogenic-RAS-selective lethal compounds and their use'20179,580,398'Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders'20178,546,421'Oncogenic-RAS-signal dependent lethal compounds'20138,535,897'Assays for non-apoptotic cell death and uses thereof'20138,518,959'Quinoxaline derivatives as antitumor agents'20138,124,365'Identification of genotype-selective anti-tumor agents'20127,615,554'Erastin and erastin binding proteins, and uses thereof'20097,358,262'Identification of genotype-selective anti-tumor agents'20087,148,216'Combinations of drugs for the treatment of neoplastic disorders'20067,109,377'Synthesis of combinatorial libraries of compounds reminiscent of natural products'20067,101,879'Treatments for neurotoxicity in Alzheimer\'s Disease'20067,067,550'Treatments for neurotoxicity in Alzheimer\'s Disease'20066,846,816'Combinations of drugs for the treatment of neoplastic disorders'20056,693,125'Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders'20046,569,853'Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders'20036,448,443'Synthesis of combinatorial libraries of compounds reminiscent of natural products'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2006Patents assigned to HARVARD COLLEGE (2)· patent assignee history
2002–2006Based in Boston, MA, US· patent location history
2003–2006Patents assigned to COMBINATORX INC (4)· patent assignee history
2006–2012Patents assigned to WHITEHEAD BIOMEDICAL INST (4)· patent assignee history
2008–2021Based in New York, NY, US· patent location history
2009–2021Patents assigned to UNIV COLUMBIA (11)· patent assignee history
2012–2013Patents assigned to STOCKWELL BRENT R (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV COLUMBIA112009–2021
COMBINATORX INC42003–2006
STOCKWELL BRENT Rself42012–2013
WHITEHEAD BIOMEDICAL INST42006–2012
HARVARD COLLEGE22002–2006
Locations
LocationPatentsSpan
New York, New York, US142008–2021
Boston, Massachusetts, US82002–2006